Evidence map›Paper›PMID 41846600›Full record

ArticleOpen forum infectious diseases2026

Targeted Genomic Surveillance Unveils Genetic Variations Linked to Regional Malaria Drug Resistance Dynamics in India.

Ajinkya Khilari, Shweta Sharma, Manali Bajpai, Anju Viswan K, Rini Chaturvedi, Bijay R Mirdha, Manju Rahi, Amit Sharma, Dhanasekaran Shanmugam

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ajinkya KhilariBiochemical Sciences Division, CSIR - National Chemical Laboratory, Pune, India.ORCID https://orcid.org/0000-0002-5884-8747
Shweta SharmaInternational Centre for Genetic Engineering and Biotechnology, New Delhi, Delhi, India.ORCID https://orcid.org/0000-0001-8060-6472
Manali BajpaiBiochemical Sciences Division, CSIR - National Chemical Laboratory, Pune, India.ORCID https://orcid.org/0009-0001-3541-9122
Anju Viswan KICMR-Vector Control Research Centre, Puducherry, India.ORCID https://orcid.org/0000-0001-7926-5826
Rini ChaturvediInternational Centre for Genetic Engineering and Biotechnology, New Delhi, Delhi, India.ORCID https://orcid.org/0000-0003-1437-5121
Bijay R MirdhaMicrobiology, All India Institute of Medical Sciences, New Delhi, India.ORCID https://orcid.org/0000-0001-7597-9426
Manju RahiICMR-Vector Control Research Centre, Puducherry, India.ORCID https://orcid.org/0000-0003-0932-0935
Amit SharmaInternational Centre for Genetic Engineering and Biotechnology, New Delhi, Delhi, India.ORCID https://orcid.org/0000-0002-3305-0034
Dhanasekaran ShanmugamBiochemical Sciences Division, CSIR - National Chemical Laboratory, Pune, India.ORCID https://orcid.org/0000-0002-3341-4846

Funding

Wellcome Trust
6 · The paper itself

Abstract

Background: India has made substantial progress in reducing Methods: We analyzed 238 Results: India's historical policy of artesunate-sulfadoxine-pyrimethamine in central India and artemether-lumefantrine in the Northeast has shaped contrasting resistance profiles. In the Northeast, chloroquine resistance persisted at high frequency ( Conclusions: India's resistance landscape is fragmented, with signals of expanding lumefantrine tolerance and importation or evolution of globally relevant mutations. These findings highlight the importance of integrating molecular genomic surveillance into malaria control policy to monitor and protect ACT effectiveness and advance malaria elimination.

Indexed as

drug resistancemalariaOxford nanoporeP. falciparumpfMDR15

Identifiers

PMID41846600
PMCPMC12989746

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.